Laura Stoppel is a Partner at RA Capital Management, where she invests across Seed, Series A–C, Early, Venture, Growth, and Late Stage companies in the United States, with sector focus areas that include Life Sciences, Biotechnology, Healthcare, and Drug Development (including hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders). She serves on the boards of Artiva Biotherapeutics, Nimbus Therapeutics, Acumen Pharmaceuticals, and Indapta Therapeutics, and has invested in companies like Artiva Biotherapeutics, Nimbus Therapeutics, Acumen Pharmaceuticals, Indapta Therapeutics, and Vor Biopharma. Previously, she held roles at RA Capital including Analyst, Associate, Senior Associate, and Principal. Laura holds a PhD in Neuroscience from MIT and a BA in Biology and Psychology from Harvard University, and she resides in Somerville, Massachusetts.
Laura Stoppel, Partner @ RA Capital. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Laura Stoppel from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Laura
Map your path to Laura instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Laura
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.